Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway.

Jianwen Hao Qizhen PengKeruo WangGe YuYi PanXiaoling DuNa HuXuening Zhang Yu Qin Huikai Li

Published in: BioMed research international (2021)

Our findings provide evidence for the possible use of alisertib in combination with lenvatinib in the treatment of HCC for better therapeutic outcomes.

Keyphrases

dna damage
oxidative stress
dna repair
combination therapy
replacement therapy
weight loss